Education
About Us
Working with TipRanks
Follow Us
MindWalk Holdings (DE:TQB0)
FRANKFURT:TQB0
TQB0 Stock Chart & Stats
€1.58
-€0.01(-2.24%)
At close: 4:00 PM EST
€1.58
-€0.01(-2.24%)
Day’s Range― - ―
52-Week Range€0.20 - €2.78
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$76.43M
Enterprise Value€75.77M
Total Cash (Recent Filing)$32.44M
Total Debt (Recent Filing)$3.72M
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Dec 11, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding46,157,310
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)0.85
Price to Sales (P/S)0.82
P/FCF Ratio-2.80
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue3.38
Enterprise Value/Gross Profit5.96
Enterprise Value/Ebitda-2.64
Forecast
1Y Price Target
$4.32Price Target Upside173.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Client AcquisitionA recent undisclosed large pharma company signed on as a client to use the platform’s software-as-a-service model.
Rebranding StrategyRebranding to showcase AI focus is expected to support greater adoption of BioStrand.
Revenue GrowthThe company reported total revenues of C$7.6M, a 46% growth compared to C$5.3M.
Bears Say
Risk FactorsRisks associated with the company's future include commercial, execution, legal, competition, and intellectual property challenges.
MindWalk Holdings News
TQB0 FAQ
What was MindWalk Holdings’s price range in the past 12 months?
MindWalk Holdings lowest stock price was €0.20 and its highest was €2.78 in the past 12 months.
What is MindWalk Holdings’s market cap?
MindWalk Holdings’s market cap is $76.43M.
When is MindWalk Holdings’s upcoming earnings report date?
MindWalk Holdings’s upcoming earnings report date is Dec 11, 2025 which is in 11 days.
How were MindWalk Holdings’s earnings last quarter?
MindWalk Holdings released its earnings results on Sep 15, 2025. The company reported -€0.056 earnings per share for the quarter, missing the consensus estimate of -€0.037 by -€0.019.
Is MindWalk Holdings overvalued?
According to Wall Street analysts MindWalk Holdings’s price is currently Undervalued.
Does MindWalk Holdings pay dividends?
MindWalk Holdings does not currently pay dividends.
What is MindWalk Holdings’s EPS estimate?
MindWalk Holdings’s EPS estimate is -0.03.
How many shares outstanding does MindWalk Holdings have?
MindWalk Holdings has 46,157,310 shares outstanding.
What happened to MindWalk Holdings’s price movement after its last earnings report?
MindWalk Holdings reported an EPS of -€0.056 in its last earnings report, missing expectations of -€0.037. Following the earnings report the stock price went down -6.461%.
Which hedge fund is a major shareholder of MindWalk Holdings?
Currently, no hedge funds are holding shares in DE:TQB0
MindWalk Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.32 (173.32% Upside)
$4.32 (173.32% Upside)
Blogger Sentiment
Bullish
DE:TQB0 Sentiment 100%
Sector Average 69%
Sector Average 69%
Technicals
SMA
Positive
20 days / 200 days
Momentum
370.58%
12-Months-Change
Fundamentals
Return on Equity
-110.94%
Trailing 12-Months
Asset Growth
-31.34%
Trailing 12-Months
Company Description
MindWalk Holdings
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
TQB0 Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive outlook for MindWalk, driven by record revenue growth, improved financial health, and strategic advancements, including a successful rebranding and strengthening of their balance sheet. However, the presence of a net loss and ongoing restructuring challenges indicate areas for further improvement.View all DE:TQB0 earnings summariesTQB0 Stock 12 Month Forecast
Average Price Target
€4.32
▲(173.32% Upside)
Technical Analysis
XBiotech
―
Relmada Therapeutics
―
PMV Pharmaceuticals
―
Werewolf Therapeutics
―
Estrella Immunopharma
―
Options Prices
Currently, No data available
---